These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8942826)

  • 41. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.
    Kwon JS; Tinker A; Pansegrau G; McAlpine J; Housty M; McCullum M; Gilks CB
    Obstet Gynecol; 2013 Jan; 121(1):14-24. PubMed ID: 23232752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Salpingo-oophorectomy at the time of vaginal hysterectomy.
    Smale LE; Smale ML; Wilkening RL; Mundy CF; Ewing TL
    Trans Pac Coast Obstet Gynecol Soc; 1978; 45():4-10. PubMed ID: 715867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The forgotten hysterectomy: the first successful abdominal hysterectomy and bilateral salpingo-oophorectomy in the United States.
    Hall JJ; Hall DJ
    Obstet Gynecol; 2006 Feb; 107(2 Pt 2):541-3. PubMed ID: 16449180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management Strategies for the Ovaries at the Time of Hysterectomy for Benign Disease.
    Matthews CA
    Obstet Gynecol Clin North Am; 2016 Sep; 43(3):539-49. PubMed ID: 27521883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
    Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A critical evaluation of the evidence for ovarian conservation versus removal at the time of hysterectomy for benign disease.
    Matthews CA
    J Womens Health (Larchmt); 2013 Sep; 22(9):755-9. PubMed ID: 23865788
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malignancies following bilateral salpingo-oophorectomy (BSO).
    Gotlieb WH; Barchana M; Ben-Baruch G; Friedman E
    Eur J Surg Oncol; 2006 Dec; 32(10):1231-4. PubMed ID: 16626923
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The risk of stroke after bilateral salpingo-oophorectomy at hysterectomy for benign diseases: A nationwide cohort study.
    Lai JC; Chou YJ; Huang N; Chen HH; Wang KL; Wang CW; Shen IH; Chang HC
    Maturitas; 2018 Aug; 114():27-33. PubMed ID: 29907243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subsequent Oophorectomy and Ovarian Cancer after Hysterectomy for Benign Gynecologic Conditions at Chiang Mai University Hospital.
    Jitkunnatumkul A; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2016; 17(8):3845-8. PubMed ID: 27644627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A substantial part of the fallopian tube is left after standard prophylactic bilateral salpingo-oophorectomy.
    Gerritzen LH; Grefte JM; Hoogerbrugge N; Bulten J; Massuger LF; de Hullu JA
    Int J Gynecol Cancer; 2006; 16(5):1940-4. PubMed ID: 17009996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.
    Obermair A; Youlden DR; Baade PD; Janda M
    Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The RANZCOG College Statement on prophylactic oophorectomy in older women undergoing hysterectomy for benign disease: is the evidence sufficient to change practice?
    Brand AH
    Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):296-300. PubMed ID: 21806570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages.
    Gierach GL; Pfeiffer RM; Patel DA; Black A; Schairer C; Gill A; Brinton LA; Sherman ME
    Menopause; 2014 Jun; 21(6):592-601. PubMed ID: 24253486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparative study of outcome of laparoscopic salpingo-oophorectomy versus open salpingo-oophorectomy.
    Leetanaporn R; Tintara H
    J Obstet Gynaecol Res; 1996 Feb; 22(1):79-83. PubMed ID: 8624898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Compliance to estrogen treatment one to three years after hysterectomy and bilateral salpingooophorectomy. The cohort's lifestyle, knowledge of ERT, benefits etc.
    Hée P
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):534-9. PubMed ID: 10376865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women.
    Appiah D; Winters SJ; Hornung CA
    Diabetes Care; 2014; 37(3):725-33. PubMed ID: 24194507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
    Benshushan A; Rojansky N; Chaviv M; Arbel-Alon S; Benmeir A; Imbar T; Brzezinski A
    Climacteric; 2009 Oct; 12(5):404-9. PubMed ID: 19479488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Women awaiting hysterectomy: a qualitative study of issues involved in decisions about oophorectomy.
    Bhavnani V; Clarke A
    BJOG; 2003 Feb; 110(2):168-74. PubMed ID: 12618161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ovarian vein thrombosis: a common incidental finding in patients who have undergone total abdominal hysterectomy and bilateral salpingo-oophorectomy with retroperitoneal lymph node dissection.
    Yassa NA; Ryst E
    AJR Am J Roentgenol; 1999 Jan; 172(1):45-7. PubMed ID: 9888736
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.